SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-032783
Filing Date
2024-07-10
Accepted
2024-07-10 07:00:19
Documents
13
Period of Report
2024-08-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A edge20019156x1_def14a.htm DEF 14A 912699
2 edge20019156x1_chair.jpg GRAPHIC 4707
3 edge20019156x1_expert.jpg GRAPHIC 4309
4 edge20019156x1_member.jpg GRAPHIC 4238
5 edge20019156x1_table01.jpg GRAPHIC 136741
6 logo_plustherapeutics.jpg GRAPHIC 42581
7 sig_marchedrick.jpg GRAPHIC 28584
8 sig_marchedrickx1.jpg GRAPHIC 21627
9 edge20019156x1_pc01.jpg GRAPHIC 700307
10 edge20019156x1_pc02.jpg GRAPHIC 742027
11 edge20019156x1_pvp01x1.jpg GRAPHIC 186378
12 edge20019156x1_pvp02x1.jpg GRAPHIC 202341
13 logo_plustherapeuticsx1.jpg GRAPHIC 33525
  Complete submission text file 0001140361-24-032783.txt   3813988
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

IRS No.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34375 | Film No.: 241108663
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)